Viewing Study NCT07453368


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-07-07 @ 7:22 PM
Study NCT ID: NCT07453368
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-09
First Post: 2026-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Orelabrutinib in the Treatment of Relapsed/Refractory AIHA
Sponsor: Peking Union Medical College Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Hemolytic Anemia (AIHA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autoimmune Hemolytic Anemia View
None Orelabrutinib View
None Treatment View
None Cohort Study View